Orion Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.3K | Hold |
|
|||||
|
2025
Q2 | $13.8K | Hold |
|
|||||
|
2025
Q1 | $12.9K | Hold |
|
|||||
|
2024
Q4 | $16.1K | Sell |
|
|||||
|
2024
Q3 | $65.3K | Buy |
|
|||||
|
2024
Q2 | $6.33K | Sell |
|
|||||
|
2024
Q1 | $43.3K | Hold |
|
|||||
|
2023
Q4 | $79.1K | Sell |
|
|||||
|
2023
Q3 | $59K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $81.4K | Hold |
|
|||||
|
2022
Q4 | $88K | Hold |
|
|||||
|
2022
Q3 | $98K | Hold |
|
|||||
|
2022
Q2 | $95K | Hold |
|
|||||
|
2022
Q1 | $117K | Hold |
|
|||||
|
2021
Q4 | $165K | Sell |
|
|||||
|
2021
Q3 | $188K | Buy |
|
|||||
|
2021
Q2 | $235K | Sell |
|
|||||
|
2021
Q1 | $161K | Sell |
|
|||||
|
2020
Q4 | $59K | Buy |
|